These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31701078)

  • 1. FOXO1 Negates the Cooperative Action of FOXL2
    Belli M; Secchi C; Stupack D; Shimasaki S
    J Endocr Soc; 2019 Nov; 3(11):2064-2081. PubMed ID: 31701078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1 mitigates the SMAD3/FOXL2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells.
    Belli M; Iwata N; Nakamura T; Iwase A; Stupack D; Shimasaki S
    Endocrinology; 2018 Apr; 159(4):1690-1703. PubMed ID: 29471425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
    Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
    PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
    Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant FOXL2
    Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
    Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential but differential role of FOXL2wt and FOXL2C134W in GDF-9 stimulation of follistatin transcription in co-operation with Smad3 in the human granulosa cell line COV434.
    Nonis D; McTavish KJ; Shimasaki S
    Mol Cell Endocrinol; 2013 Jun; 372(1-2):42-8. PubMed ID: 23523567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
    Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
    PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulosa cell tumor mutant FOXL2C134W suppresses GDF-9 and activin A-induced follistatin transcription in primary granulosa cells.
    McTavish KJ; Nonis D; Hoang YD; Shimasaki S
    Mol Cell Endocrinol; 2013 Jun; 372(1-2):57-64. PubMed ID: 23567549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
    Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
    Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
    Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
    J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
    Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
    J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
    Cheng JC; Klausen C; Leung PC
    PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
    Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
    Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXL2
    Fuller PJ; Nguyen T; Alexiadis M; Chu S
    J Pathol; 2022 Jan; 256(1):1-3. PubMed ID: 34687235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.
    L'Hôte D; Georges A; Todeschini AL; Kim JH; Benayoun BA; Bae J; Veitia RA
    Hum Mol Genet; 2012 Jul; 21(14):3264-74. PubMed ID: 22544055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
    Leung DTH; Fuller PJ; Chu S
    Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.